| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.7 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |